期刊文献+

基于专利申请的乳腺癌人工智能诊断技术领域创新主体竞争态势分析 被引量:1

Study of Competition Situation of Innovation Subjects of Breast Cancer Artificial Intelligence Diagnosis Technology Based on Patent Applications
下载PDF
导出
摘要 近年来人工智能技术在图像处理方面取得了巨大的发展,乳腺癌人工智能诊断技术是人工智能技术在医学影像方面相对成熟的应用。本文通过对乳腺癌人工智能诊断技术领域的专利申请进行检索和分析,从乳腺癌人工智能诊断技术发展趋势、创新主体和专利竞争态势3个方面对乳腺癌人工智能诊断国内创新主体的地位进行评价,揭示乳腺癌人工智能诊断技术领域创新主体的竞争形式,为国内创新主体未来的技术发展和专利布局提供参考。 In recent years,artificial intelligence technology has made great progress in image processing.Breast cancer artificial intelligence diagnosis technology is a relatively mature application of artificial intelligence technology in medical imaging.Through searching and analyzing the patent applications in the field of breast cancer artificial intelligence diagnosis technology,this paper evaluated the position of domestic innovation subjects in breast cancer artificial intelligence diagnosis from three aspects:the development trend analysis of breast cancer artificial intelligence diagnosis technology,the innovation subject analysis and the patent competition situation analysis,and reveals the competition form of innovation subjects in the field of breast cancer artificial intelligence diagnosis technology.It provides reference for the future technological development and patent layout of domestic innovation subjects.
作者 石艳丽 马镯 谢春岺 刘超 赵怡 SHI Yanli;MA Zhuo;XIE Chunling;LIU Chao;ZHAO Yi(Patent Examination Cooperation(Beijing)Center of the Patent Office,CNIPA,Beijing 100083,China)
出处 《中国医疗设备》 2023年第4期129-135,共7页 China Medical Devices
关键词 乳腺癌 人工智能 诊断技术 创新主体 竞争态势 breast cancer artificial intelligence diagnosis techniques innovation subject competition situation
  • 相关文献

参考文献6

二级参考文献70

  • 1钱其军,吴孟超.肿瘤精准细胞免疫治疗:梦想照进现实[J].中国肿瘤生物治疗杂志,2015,22(2):151-158. 被引量:28
  • 2邓洪新,魏于全.肿瘤基因治疗的研究现状和展望[J].中国肿瘤生物治疗杂志,2015,22(2):170-176. 被引量:26
  • 3吴峰梅,李永忠.基于Internet网的专利情报分析与应用研究[J].现代情报,2006,26(10):69-72. 被引量:8
  • 4Siegel R,Ma J,Zou Z,et al. Cancer statistics,201d[J]. CA Cancer J Clin, 2014,64(1) : 9-29.
  • 5DeSantis CE,Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics,2014 [J]. CA Cancer J Clin, 2014,64(4) : 252-271.
  • 6Rane RA,Bangalore PK,Naphade SS,et al. Design and synthesis of novel antineoplastic agents inspired from ma- rine bromopyrrole alkaloids [J]. Anticancer Agents Med Chem,2015,15(5) :548-554.
  • 7Nardon C ,Chiara F,Brustolin L,et al. Gold (III)-pyrro- lidinedithiocarbamato derivatives as antineoplastic agents [J]. Chemistry Open,2015,4(2): 183-191.
  • 8Javid A,Ahmadian S,Saboury AA,et al. Bioeompatible APTES-PEG modified magnetite nanoparticles:effeetive carriers of antineoplastic agents to ovarian cancer[J]. Appl Biochem Biotechnol, 2014,173(1) : 36-54.
  • 9Florou D ,Mavridis K,Scorilas A. The kallikrein-related peptidase 13 (KLK13) gene is substantially up-regulated after exposure of gastric cancer cells to antineoplastic a- gents [J]. Tumour Biol, 2012,33(6) : 2069-2078.
  • 10Li J,Wang LJ,Ying X,et al. Immunodiagnostic value of combined detection of autoantibodies to tumor-associated antigens as biomarkers in pancreatic cancer [J]. Scand J Immunol,2012,75(3) :342-349.

共引文献64

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部